Myeloid cell-mediated killing of B-ALL by CD38 and CD20 IgA antibody variants is enhanced by CD47/SIRPα interference.
Saved in:
| Title: | Myeloid cell-mediated killing of B-ALL by CD38 and CD20 IgA antibody variants is enhanced by CD47/SIRPα interference. |
|---|---|
| Authors: | Lustig M; Department of Medicine II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010), University Medical Center Schleswig-Holstein, Kiel, Germany., Kowol M; Department of Medicine II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany., Hartmann AM; Department of Medicine II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010), University Medical Center Schleswig-Holstein, Kiel, Germany., van der Peet IC; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands., Jansen MJH; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands., Iben K; Department of Medicine II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010), University Medical Center Schleswig-Holstein, Kiel, Germany., Winterberg D; Department of Medicine II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany., Krohn S; Department of Medicine II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany., Baumann N; Department of Medicine II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany., Rösner T; Department of Medicine II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany., Bendig S; Department of Medicine II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010), University Medical Center Schleswig-Holstein, Kiel, Germany., Hahn C; Department of Medicine II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany., Wurm AA; Pediatric Hematology/Oncology, TU Dresden and University Medical Center Carl Gustav Carus, Dresden, Germany.; National Center for Tumor Diseases (NCT), Dresden Partner Site, Dresden, Germany., Gehlert CL; Department of Medicine II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany., Denker M; Department of Medicine II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany., Suwanchaikasem P; Baiya Phytopharm Co, Ltd, Bangkok, Thailand., Macarrón Palacios A; GenCC GmbH & Co KG, Heidelberg, Germany., Schwartz S; Department of Hematology, Oncology and Cancer Immunology (Campus Benjamin Franklin), Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium, Partner Site Berlin, a partnership between German Cancer Research Center and Charité Universitätsmedizin Berlin, Berlin, Germany., Brüggemann M; Department of Medicine II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010), University Medical Center Schleswig-Holstein, Kiel, Germany., Burger R; Department of Medicine II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany., Schmitt K; Department of Molecular Microbiology and Genetics, Institute of Microbiology and Genetics, Georg-August-University of Göttingen, Göttingen, Germany.; Service Unit LCMS Protein Analytics, Göttingen Center for Molecular Biosciences (GZMB), Georg-August-University of Göttingen, Göttingen, Germany., Klausz K; Department of Medicine II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010), University Medical Center Schleswig-Holstein, Kiel, Germany., Valerius O; Department of Molecular Microbiology and Genetics, Institute of Microbiology and Genetics, Georg-August-University of Göttingen, Göttingen, Germany.; Service Unit LCMS Protein Analytics, Göttingen Center for Molecular Biosciences (GZMB), Georg-August-University of Göttingen, Göttingen, Germany., Stölzel F; Department of Medicine II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010), University Medical Center Schleswig-Holstein, Kiel, Germany., Bastian L; Department of Medicine II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010), University Medical Center Schleswig-Holstein, Kiel, Germany., Baldus CD; Department of Medicine II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010), University Medical Center Schleswig-Holstein, Kiel, Germany., Peipp M; Department of Medicine II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010), University Medical Center Schleswig-Holstein, Kiel, Germany., Leusen JHW; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands., Schewe DM; Clinical Research Unit 'CATCH ALL' (KFO 5010), University Medical Center Schleswig-Holstein, Kiel, Germany.; Pediatric Hematology/Oncology, TU Dresden and University Medical Center Carl Gustav Carus, Dresden, Germany.; National Center for Tumor Diseases (NCT), Dresden Partner Site, Dresden, Germany., Valerius T; Department of Medicine II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010), University Medical Center Schleswig-Holstein, Kiel, Germany. |
| Source: | Blood neoplasia [Blood Neoplasia] 2026 May 05; Vol. 3 (3), pp. 100242. Date of Electronic Publication: 2026 May 05 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 9918841988906676 Publication Model: eCollection Cited Medium: Internet ISSN: 2950-3280 (Electronic) Linking ISSN: 29503280 NLM ISO Abbreviation: Blood Neoplasia Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42327600 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Myeloid cell-mediated killing of B-ALL by CD38 and CD20 IgA antibody variants is enhanced by CD47/SIRPα interference. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Lustig+M%22">Lustig M</searchLink>; Department of Medicine II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010), University Medical Center Schleswig-Holstein, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Kowol+M%22">Kowol M</searchLink>; Department of Medicine II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Hartmann+AM%22">Hartmann AM</searchLink>; Department of Medicine II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010), University Medical Center Schleswig-Holstein, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22van+der+Peet+IC%22">van der Peet IC</searchLink>; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Jansen+MJH%22">Jansen MJH</searchLink>; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Iben+K%22">Iben K</searchLink>; Department of Medicine II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010), University Medical Center Schleswig-Holstein, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Winterberg+D%22">Winterberg D</searchLink>; Department of Medicine II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Krohn+S%22">Krohn S</searchLink>; Department of Medicine II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Baumann+N%22">Baumann N</searchLink>; Department of Medicine II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Rösner+T%22">Rösner T</searchLink>; Department of Medicine II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Bendig+S%22">Bendig S</searchLink>; Department of Medicine II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010), University Medical Center Schleswig-Holstein, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Hahn+C%22">Hahn C</searchLink>; Department of Medicine II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Wurm+AA%22">Wurm AA</searchLink>; Pediatric Hematology/Oncology, TU Dresden and University Medical Center Carl Gustav Carus, Dresden, Germany.; National Center for Tumor Diseases (NCT), Dresden Partner Site, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Gehlert+CL%22">Gehlert CL</searchLink>; Department of Medicine II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Denker+M%22">Denker M</searchLink>; Department of Medicine II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Suwanchaikasem+P%22">Suwanchaikasem P</searchLink>; Baiya Phytopharm Co, Ltd, Bangkok, Thailand.<br /><searchLink fieldCode="AU" term="%22Macarrón+Palacios+A%22">Macarrón Palacios A</searchLink>; GenCC GmbH & Co KG, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Schwartz+S%22">Schwartz S</searchLink>; Department of Hematology, Oncology and Cancer Immunology (Campus Benjamin Franklin), Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium, Partner Site Berlin, a partnership between German Cancer Research Center and Charité Universitätsmedizin Berlin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Brüggemann+M%22">Brüggemann M</searchLink>; Department of Medicine II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010), University Medical Center Schleswig-Holstein, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Burger+R%22">Burger R</searchLink>; Department of Medicine II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Schmitt+K%22">Schmitt K</searchLink>; Department of Molecular Microbiology and Genetics, Institute of Microbiology and Genetics, Georg-August-University of Göttingen, Göttingen, Germany.; Service Unit LCMS Protein Analytics, Göttingen Center for Molecular Biosciences (GZMB), Georg-August-University of Göttingen, Göttingen, Germany.<br /><searchLink fieldCode="AU" term="%22Klausz+K%22">Klausz K</searchLink>; Department of Medicine II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010), University Medical Center Schleswig-Holstein, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Valerius+O%22">Valerius O</searchLink>; Department of Molecular Microbiology and Genetics, Institute of Microbiology and Genetics, Georg-August-University of Göttingen, Göttingen, Germany.; Service Unit LCMS Protein Analytics, Göttingen Center for Molecular Biosciences (GZMB), Georg-August-University of Göttingen, Göttingen, Germany.<br /><searchLink fieldCode="AU" term="%22Stölzel+F%22">Stölzel F</searchLink>; Department of Medicine II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010), University Medical Center Schleswig-Holstein, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Bastian+L%22">Bastian L</searchLink>; Department of Medicine II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010), University Medical Center Schleswig-Holstein, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Baldus+CD%22">Baldus CD</searchLink>; Department of Medicine II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010), University Medical Center Schleswig-Holstein, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Peipp+M%22">Peipp M</searchLink>; Department of Medicine II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010), University Medical Center Schleswig-Holstein, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Leusen+JHW%22">Leusen JHW</searchLink>; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Schewe+DM%22">Schewe DM</searchLink>; Clinical Research Unit 'CATCH ALL' (KFO 5010), University Medical Center Schleswig-Holstein, Kiel, Germany.; Pediatric Hematology/Oncology, TU Dresden and University Medical Center Carl Gustav Carus, Dresden, Germany.; National Center for Tumor Diseases (NCT), Dresden Partner Site, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Valerius+T%22">Valerius T</searchLink>; Department of Medicine II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010), University Medical Center Schleswig-Holstein, Kiel, Germany. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229918841988906676%22">Blood neoplasia</searchLink> [Blood Neoplasia] 2026 May 05; Vol. 3 (3), pp. 100242. <i>Date of Electronic Publication: </i>2026 May 05 (<i>Print Publication: </i>2026). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%2C+Inc%22">Elsevier, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9918841988906676 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2950-3280 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2229503280%22">29503280 </searchLink><i>NLM ISO Abbreviation: </i>Blood Neoplasia <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42327600 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.bneo.2026.100242 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 100242 Titles: – TitleFull: Myeloid cell-mediated killing of B-ALL by CD38 and CD20 IgA antibody variants is enhanced by CD47/SIRPα interference. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Lustig M – PersonEntity: Name: NameFull: Kowol M – PersonEntity: Name: NameFull: Hartmann AM – PersonEntity: Name: NameFull: van der Peet IC – PersonEntity: Name: NameFull: Jansen MJH – PersonEntity: Name: NameFull: Iben K – PersonEntity: Name: NameFull: Winterberg D – PersonEntity: Name: NameFull: Krohn S – PersonEntity: Name: NameFull: Baumann N – PersonEntity: Name: NameFull: Rösner T – PersonEntity: Name: NameFull: Bendig S – PersonEntity: Name: NameFull: Hahn C – PersonEntity: Name: NameFull: Wurm AA – PersonEntity: Name: NameFull: Gehlert CL – PersonEntity: Name: NameFull: Denker M – PersonEntity: Name: NameFull: Suwanchaikasem P – PersonEntity: Name: NameFull: Macarrón Palacios A – PersonEntity: Name: NameFull: Schwartz S – PersonEntity: Name: NameFull: Brüggemann M – PersonEntity: Name: NameFull: Burger R – PersonEntity: Name: NameFull: Schmitt K – PersonEntity: Name: NameFull: Klausz K – PersonEntity: Name: NameFull: Valerius O – PersonEntity: Name: NameFull: Stölzel F – PersonEntity: Name: NameFull: Bastian L – PersonEntity: Name: NameFull: Baldus CD – PersonEntity: Name: NameFull: Peipp M – PersonEntity: Name: NameFull: Leusen JHW – PersonEntity: Name: NameFull: Schewe DM – PersonEntity: Name: NameFull: Valerius T IsPartOfRelationships: – BibEntity: Dates: – D: 05 M: 05 Text: 2026 May 05 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2950-3280 Numbering: – Type: volume Value: 3 – Type: issue Value: 3 Titles: – TitleFull: Blood neoplasia Type: main |
| ResultId | 1 |